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REPLY
We are grateful to Dr. Bellenger for his interesting comments. We
share his enthusiasm regarding the potential of cardiac magnetic
resonance (CMR) to provide a guide to revascularization in patients
presenting with acute coronary syndromes and also in other clinical
scenarios.
Some of the information Dr. Bellenger requests is indeed
inherent in our data (1). Of the 56 patients with significant
coronary artery disease (CAD) in our study, 49 had perfusion
defects (the sensitivity of perfusion analysis to detect the presence
of CAD on X-ray angiography was therefore 87.5%, as reported in
our study). Seven patients thus had no perfusion defects on CMR
despite the presence of significant CAD on X-ray angiography.
Only three patients in our population showed transmural scar on
late contrast-enhanced CMR imaging. Two of these patients
underwent percutaneous intervention to vessels supplying myocar-
dium that appeared on CMR to be predominantly nonviable (one
of these is shown in Figure 4C of our study [1]).
However, other than reporting these results, our study design
does not permit us to draw conclusions regarding the appropriate-
ness of revascularization decisions in these patients. In the absence
of a true standard for the detection of “significant” CAD, we used
X-ray angiography as the reference test to determine the need for
coronary revascularization therapy. We cannot therefore conclude
that in patients with discrepant results between CMR and X-ray
angiography, coronary revascularization was inappropriate or un-
necessary.
Our study (1) is the first report of using CMR in patients with
acute coronary syndromes. In this work it was our aim to establish
whether CMR can be applied safely to this group of patients and
whether it can accurately detect CAD. We fully agree with Dr.
Bellenger that the potential future role of CMR, as we have
discussed in our report, could exceed this relatively narrow appli-
cation we have studied, and could include guiding revascularization
decisions by providing comprehensive data on myocardial func-
tion, perfusion, and viability. This potential role should be ex-
plored in future work with an appropriately designed study.
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